Actively Recruiting

Phase 1
Age: 18Years - 60Years
All Genders
NCT06558253

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

Led by Anhui Provincial Hospital · Updated on 2024-12-18

12

Participants Needed

1

Research Sites

95 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To assess the safety and efficacy of coenzyme I for injection in promoting hematopoietic recovery after single-unit unrelated cord blood transplantation in hematological malignancies.

CONDITIONS

Official Title

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 60 years (inclusive) at screening
  • Diagnosed with hematological malignancies to receive single-unit unrelated cord blood transplantation for the first time
  • No severe organ failure and no active infections
  • ECOG performance status of 0-2
  • Voluntarily participating in the clinical trial with full understanding and signed informed consent form
Not Eligible

You will not qualify if you...

  • Severe organ dysfunction or disease, including heart, liver, kidney, or pancreas
  • Pregnant patients
  • Refusal by patient or authorized family members to receive Coenzyme I for injection
  • Life-threatening disease, physical condition, or organ dysfunction that may risk safety or study results
  • Drug dependence, uncontrolled psychiatric disorders, or cognitive impairment
  • Participation in other clinical studies affecting hematopoietic recovery within 3 months
  • Considered unsuitable by investigator due to anticipated inability to adhere to treatment or examinations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

Hefei, Anhui, China, 230036

Actively Recruiting

Loading map...

Research Team

X

Xiaoyu Zhu, Ph.D

CONTACT

Y

Yue Wu, M.D

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT | DecenTrialz